NCT05863221 - ZYNRELEF® for Postoperative Analgesia After Laparoscopic Sleeve Gastrectomy | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

May 9, 2023

Primary Completion Date

October 9, 2024

Study Completion Date

October 9, 2024

Conditions

Post Operative Pain, AcuteBariatric Surgery CandidatePostoperative Pain

Interventions

DRUG

ZYNRELEF 200Mg-6Mg Extended-Release Solution

ZYNRELEF® is an extended-release, fixed-ratio combination product that contains bupivacaine (a local anesthetic as the free base) and low-dose meloxicam (an NSAID) incorporated in a bioerodible polymer (termed Biochronomer®).

Trial Locations (1)

01040

RECRUITING

Holyoke Medical Center, Holyoke